Navigation Links
BDSI secures US commercial partnership for BEMA Fentanyl with Meda AB
Date:9/5/2007

Sales, marketing, and clinical studies, post-approval, to support competitive claims and expanded indications will be the responsibility of Meda. Meda and BDSI will also collaborate on expanding the indications for BEMA Fentanyl, which could increase fourfold the market potential. Meda will fund this development, and will also get a right of first refusal on the commercialization rights to future development projects based on BEMA Fentanyl.

Meda and BDSI started their collaboration in 2006 with BEMA Fentanyl for all the European markets. In July this year, Meda announced the acquisition of the U.S. specialty pharma company MedPointe Inc, an acquisition which immediately gave access to a strong platform in the US with about 500 employees within marketing and sales. Through this acquisition and Medas rapid development in Europe, Medas annual turnover has increased from around $30 million in 2002 to now approaching $1.4 billion (including MedPointe).

This is a landmark event for BDSI, and based on our standing relationship with Meda in Europe, we believe Meda is going to be a terrific marketing partner for BEMA Fentanyl here in the U.S. said Dr. Mark A. Sirgo, BDSIs President and CEO. Meda already knows BDSI and the product they will be selling here in the U.S. When they recently entered the U.S. marketplace by purchasing MedPointe, they actively pursued the U.S. BEMA Fentanyl opportunity with us given the natural strategic fit. We believe Meda provides BDSI a commercial partner with global reach and abundant resources to support our lead product. Importantly, this transaction, along with the anticipated submission of our BEMA Fentanyl NDA, will allow us to achieve BDSIs highest priorities for 2007. We could not be more pleased.

Anders Lonner, CEO of Meda, stated It is optimal timing for us to acquire the BEMA Fentanyl rights so soon after the acquisition of our U.S. platform MedPointe. BEMA Fentanyl represents a huge opportunity
'/>"/>

Contact: Bill Douglass
bdouglass@investorrelationsgroup.com
212-825-3210
BioDelivery Sciences
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. TV drug commercials prompt prescriptions
2. Commercialization of Biotech Discoveries, An Encouragement For Researchers
3. A Move To Help Commercial Sex Workers Quit Their Business
4. Commercial grape juices and vinegars found rich in antioxidants
5. Widespread Commercialisation Of Human Organ Donation In China
6. Commercialization of drugs by fast tracking is a cause of concern
7. Formula milk suffering due to commercial interests
8. Spine Gourd Variety Helpful For Diabetics Is Ready For Commercial Cultivation
9. Updated Sleep Apnea Screening Recommended for Commercial Drivers
10. The Psyche Behind Drug Commercials
11. Magnets in Commercial Products may Cause a Fatal Attraction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)..., Calif., Jan. 8 VNUS Me...ing provider of medical devices for the minimally ... announced its plans to present at the 27th Annual...uary 12 - 15, 2009, at the Westin St. Francis Hote...e Brian Farley, President and Chief Executive Offi...
(Date:1/8/2009)...for Seniors Unlocks Potential, Encourages Growth a...e/ -- Brookdale Senior Living, http:// www.br...r of senior living communities in the United State...ns 2009. A yearlong life enrichment and dining pro...dents and communities, Celebrations offers themed ...
(Date:1/8/2009)...ncer is much more likely to be deadly for women an... to explain the phenomenon account for only part o...eir white and male counterparts, according to resu...Cancer . , The results present a stark question ...stage of the disease upon diagnosis don,t account ...
(Date:1/8/2009)... Agency will lead public relations ef...ducts , Los Angeles, CA (..., has selected GolinHarris as agency of record to ...g; LLC, a wholly owned subsidiary. The agency is c...saging, traditional media outreach and developing ...
Breaking Medicine News(10 mins):Health News:Senior Living Provider Invites Residents to Dream. Dare. Discover! 2Health News:Senior Living Provider Invites Residents to Dream. Dare. Discover! 3Health News:Why bladder cancer is deadlier for some 2Health News:Why bladder cancer is deadlier for some 3Health News:Why bladder cancer is deadlier for some 4Health News:Matrixx Initiatives Selects GolinHarris as Agency of Record for Zicam Brand 2Health News:Matrixx Initiatives Selects GolinHarris as Agency of Record for Zicam Brand 3
...A) will release its approval for consumption of me...federal scientists, Larisa Rudenko and John C. Ma...eat and milk of cloned animals and their offspring...e food products from the cloned animals from norma...
...ter cracker when she was 14 months old that left h...nut is enough to trigger an allergic reaction in p...eth, at 4 1/2, in a landmark experiment that set t... amounts of the very foods that endanger them even...
...ve a shorter life span than those with few kids an...s a new study.// Researchers led by Dustin Penn an...tudies of 21,000 couples living in Utah between 18...al of 174,000 children. They found that the coupl...
... Medecins Sans Frontieres, in their article sugges...he international community that health should be c...as been paid to the ensuing legal obligation to pr...re two major reasons, say the authors, why many co...
Other Medicine News:Health News:Is Your Child Allergic To Peanuts? 2Health News:A World Health Insurance Needed: Report 2
(Date:1/7/2009)...D, England, January 7 Circassia Lt...on allergy and critical care, today,announced tha...n 2008 with,its ToleroMune(R) anti-allergy techno...itment for a further phase II clinical trial in ca..., has recruited 120 patients with confirmed,cat a...
(Date:1/6/2009)...gnificance of AHCC for maintaining a healthy immun.../ -- A recently published study in Nutrition and ...Medical University in Osaka, Japan has shown that ...immune function by increasing the number of dendri...system responsible for presenting foreign substanc...
(Date:1/6/2009)... Jan. 6 The Michael J. ...on to four industry research teams for pre-clinica...on,s disease. , , The funding was awarded under...tive. This program, first launched in 2006, suppo...nson,s research. TDI is part of MJFF,s focus on ...
(Date:1/6/2009)..., Mass., Jan. 6 Cequent Pharmaceut...cts to deliver RNAi-based treatments to prevent an...has recently completed a successful toxicology stu... tk RNAi therapeutic targeting the primary oncoge...tous polyposis). FAP is an inherited gastrointesti...
Breaking Medicine Technology:Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Lap Band 26quot 3BTell All 26quot 3B Warns of Patients Becoming Lap Band 26quot 3BOrphans 26quot 3B 25144 1Lap Band 26quot 3BTell All 26quot 3B Warns of Patients Becoming Lap Band 26quot 3BOrphans 26quot 3B 25144 2Lap Band 26quot 3BTell All 26quot 3B Warns of Patients Becoming Lap Band 26quot 3BOrphans 26quot 3B 25144 3Lap Band 26quot 3BTell All 26quot 3B Warns of Patients Becoming Lap Band 26quot 3BOrphans 26quot 3B 25144 4H 26amp 3B S Business Services Offers Parents Tools to Fight Drug Abuse 25140 1H 26amp 3B S Business Services Offers Parents Tools to Fight Drug Abuse 25140 2H 26amp 3B S Business Services Offers Parents Tools to Fight Drug Abuse 25140 3 Dr Robert N Butler Appointed to Board of Directors of BioTime Inc 6990 1 Dr Robert N Butler Appointed to Board of Directors of BioTime Inc 6990 2 Dr Robert N Butler Appointed to Board of Directors of BioTime Inc 6990 3 Dr Robert N Butler Appointed to Board of Directors of BioTime Inc 6990 4Providence Service Corporation Releases Second Quarter Results 25132 1Providence Service Corporation Releases Second Quarter Results 25132 2Providence Service Corporation Releases Second Quarter Results 25132 3Providence Service Corporation Releases Second Quarter Results 25132 4Providence Service Corporation Releases Second Quarter Results 25132 5Providence Service Corporation Releases Second Quarter Results 25132 6Providence Service Corporation Releases Second Quarter Results 25132 7Providence Service Corporation Releases Second Quarter Results 25132 8Providence Service Corporation Releases Second Quarter Results 25132 9Providence Service Corporation Releases Second Quarter Results 25132 10Providence Service Corporation Releases Second Quarter Results 25132 11Providence Service Corporation Releases Second Quarter Results 25132 12
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products: